Literature DB >> 26597618

Bladder cancer: A step closer to individualized treatment for bladder cancer.

Samer L Traboulsi1, Wassim Kassouf1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26597618     DOI: 10.1038/nrurol.2015.265

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy.

Authors:  Ryo Takata; Toyomasa Katagiri; Mitsugu Kanehira; Taro Shuin; Tsuneharu Miki; Mikio Namiki; Kenjiro Kohri; Tatsuhiko Tsunoda; Tomoaki Fujioka; Yusuke Nakamura
Journal:  Cancer Sci       Date:  2007-01       Impact factor: 6.716

2.  MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.

Authors:  Thomas Powles; Joseph Paul Eder; Gregg D Fine; Fadi S Braiteh; Yohann Loriot; Cristina Cruz; Joaquim Bellmunt; Howard A Burris; Daniel P Petrylak; Siew-leng Teng; Xiaodong Shen; Zachary Boyd; Priti S Hegde; Daniel S Chen; Nicholas J Vogelzang
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

3.  P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.

Authors:  Wassim Kassouf; Philippe E Spiess; Gordon A Brown; Mark F Munsell; H Barton Grossman; Arlene Siefker-Radtke; Colin P N Dinney; Ashish M Kamat
Journal:  Eur Urol       Date:  2007-04-10       Impact factor: 20.096

4.  Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.

Authors:  Woonyoung Choi; Sima Porten; Seungchan Kim; Daniel Willis; Elizabeth R Plimack; Jean Hoffman-Censits; Beat Roth; Tiewei Cheng; Mai Tran; I-Ling Lee; Jonathan Melquist; Jolanta Bondaruk; Tadeusz Majewski; Shizhen Zhang; Shanna Pretzsch; Keith Baggerly; Arlene Siefker-Radtke; Bogdan Czerniak; Colin P N Dinney; David J McConkey
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

5.  Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology.

Authors:  Jeffrey S Damrauer; Katherine A Hoadley; David D Chism; Cheng Fan; Christopher J Tiganelli; Sara E Wobker; Jen Jen Yeh; Matthew I Milowsky; Gopa Iyer; Joel S Parker; William Y Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-11       Impact factor: 11.205

6.  Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma.

Authors:  Eliezer M Van Allen; Kent W Mouw; Philip Kim; Gopa Iyer; Nikhil Wagle; Hikmat Al-Ahmadie; Cong Zhu; Irina Ostrovnaya; Gregory V Kryukov; Kevin W O'Connor; John Sfakianos; Ilana Garcia-Grossman; Jaegil Kim; Elizabeth A Guancial; Richard Bambury; Samira Bahl; Namrata Gupta; Deborah Farlow; Angela Qu; Sabina Signoretti; Justine A Barletta; Victor Reuter; Jesse Boehm; Michael Lawrence; Gad Getz; Philip Kantoff; Bernard H Bochner; Toni K Choueiri; Dean F Bajorin; David B Solit; Stacey Gabriel; Alan D'Andrea; Levi A Garraway; Jonathan E Rosenberg
Journal:  Cancer Discov       Date:  2014-08-05       Impact factor: 39.397

7.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Authors:  H Barton Grossman; Ronald B Natale; Catherine M Tangen; V O Speights; Nicholas J Vogelzang; Donald L Trump; Ralph W deVere White; Michael F Sarosdy; David P Wood; Derek Raghavan; E David Crawford
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

8.  Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.

Authors:  Stephen H Culp; Rian J Dickstein; H Barton Grossman; Shanna M Pretzsch; Sima Porten; Siamak Daneshmand; Jie Cai; Susan Groshen; Arlene Siefker-Radtke; Randall E Millikan; Bogdan Czerniak; Neema Navai; Matthew F Wszolek; Ashish M Kamat; Colin P N Dinney
Journal:  J Urol       Date:  2013-07-30       Impact factor: 7.450

9.  Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.

Authors:  Elizabeth R Plimack; Roland L Dunbrack; Timothy A Brennan; Mark D Andrake; Yan Zhou; Ilya G Serebriiskii; Michael Slifker; Katherine Alpaugh; Essel Dulaimi; Norma Palma; Jean Hoffman-Censits; Marijo Bilusic; Yu-Ning Wong; Alexander Kutikov; Rosalia Viterbo; Richard E Greenberg; David Y T Chen; Costas D Lallas; Edouard J Trabulsi; Roman Yelensky; David J McConkey; Vincent A Miller; Erica A Golemis; Eric A Ross
Journal:  Eur Urol       Date:  2015-08-01       Impact factor: 20.096

10.  Comprehensive molecular characterization of urothelial bladder carcinoma.

Authors: 
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.